The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patients

Por Pineo, Graham F, Lin, Jay, Annemans, Lieven
Publicado em 2012

Real-world medication persistence and outcomes associated with basal insulin and glucagon-like peptide 1 receptor agonist free-dose combination therapy in patients with type 2 diab...

Por Lin, Jay, Lingohr-Smith, Melissa, Fan, Tao
Publicado no Clinicoecon Outcomes Res (2016)

Medical Care Costs Associated with Rheumatoid Arthritis in the US: A Systematic Literature Review and Meta-analysis

Por Hresko, Andrew, Lin, Jay, Solomon, Daniel H.
Publicado no Arthritis Care Res (Hoboken) (2018)

Effect of Prior Biologic Use on Cost-Effectiveness of Brodalumab vs. Ustekinumab for Treatment of Moderate-to-Severe Psoriasis in the United States

Por Feldman, Steven R., Rastogi, Shipra, Lin, Jay
Publicado no Dermatol Ther (Heidelb) (2018)

Rate of deep-vein thrombosis and pulmonary embolism during the care continuum in patients with acute ischemic stroke in the United States

Por Amin Alpesh N, Lin Jay, Thompson Stephen, Wiederkehr Daniel
Publicado em 2013-02-01

Are There Any Differences in the Clinical and Economic Outcomes Between US Cancer Patients Receiving Appropriate or Inappropriate Venous Thromboembolism Prophylaxis?

Por Amin, Alpesh N., Lin, Jay, Yang, Guiping, Stemkowski, Stephen
Publicado em 2009

Rate of deep-vein thrombosis and pulmonary embolism during the care continuum in patients with acute ischemic stroke in the United States

Por Amin, Alpesh N, Lin, Jay, Thompson, Stephen, Wiederkehr, Daniel
Publicado em 2013

Impact of Dronedarone Treatment on Healthcare Resource Utilization in Patients with Atrial Fibrillation/Flutter

Por Kim, Michael H., Lin, Jay, Jhaveri, Mehul, Koren, Andrew
Publicado em 2014

National Variations in Comorbidities, Glycosylated Hemoglobin Reduction, and Insulin Dosage in Asian Patients with Type 2 Diabetes: The FINE-Asia Registry

Por Ji, Linong, Tsai, Shih-Tzer, Lin, Jay, Bhambani, Sanjiv
Publicado no Diabetes Ther (2015)

Temporal trend in the use of hysteroscopic vs laparoscopic sterilization and the characteristics of commercially insured and Medicaid-insured females in the US who have had the pro...

Por Carney, Patricia I, Lin, Jay, Xia, Fang, Law, Amy
Publicado no Int J Womens Health (2016)

Novel hepatitis E like virus found in Swedish moose

Por Lin, Jay, Norder, Heléne, Uhlhorn, Henrik, Belák, Sándor, Widén, Frederik
Publicado em 2014

Does Device Make Any Difference? A Real-world Retrospective Study of Insulin Treatment Among Elderly Patients With Type 2 Diabetes

Por Miao, Raymond, Wei, Wenhui, Lin, Jay, Xie, Lin, Baser, Onur
Publicado no J Diabetes Sci Technol (2014)

Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States

Por Khorana, Alok A, Dalal, Mehul R, Lin, Jay, Connolly, Gregory C
Publicado em 2013

PCR detection and analyzis of potentially zoonotic Hepatitis E virus in French rats

Por Widén, Frederik, Ayral, Florence, Artois, Marc, Olofson, Ann-Sophie, Lin, Jay
Publicado em 2014

Treatment Patterns and Antipsychotic Medication Adherence Among Commercially Insured Patients With Schizoaffective Disorder in the United States

Por Joshi, Kruti, Lin, Jay, Lingohr-Smith, Melissa, Fu, Dong-Jing, Muser, Erik
Publicado no J Clin Psychopharmacol (2016)

Impact of patient and treatment characteristics on glycemic control and hypoglycemia in patients with type 2 diabetes initiated to insulin glargine or NPH: A post hoc, pooled, pati...

Por Porcellati, Francesca, Lin, Jay, Lucidi, Paola, Bolli, Geremia B., Fanelli, Carmine G.
Publicado no Medicine (Baltimore) (2017)

Influence of the duration of hospital length of stay on frequency of prophylaxis and risk for venous thromboembolism among patients hospitalized for acute medical illnesses in the...

Por Amin, Alpesh, Neuman, W Richey, Lingohr-Smith, Melissa, Menges, Brandy, Lin, Jay
Publicado no Drugs Context (2019)

Venous Thromboembolism Prophylaxis and Risk for Acutely Medically Ill Patients Stratified by Different Ages and Renal Disease Status

Por Amin, Alpesh, Neuman, W. Richey, Lingohr-Smith, Melissa, Menges, Brandy, Lin, Jay
Publicado no Clin Appl Thromb Hemost (2019)

Cost Burden of Cardiovascular Hospitalization and Mortality in ATHENA‐Like Patients With Atrial Fibrillation/Atrial Flutter in the United States

Por Naccarelli, Gerald V., Johnston, Stephen S., Lin, Jay, Patel, Parag P., Schulman, Kathy L.
Publicado no Clin Cardiol (2010)

Medical Costs of Oral Anticoagulants vs Warfarin for Atrial Fibrillation Patients with Different Stroke Risks

Por Deitelzweig, Steve, Amin, Alpesh, Jing, Yonghua, Makenbaeva, Dinara, Wiederkehr, Daniel, Lin, Jay, Graham, John
Publicado em 2013